Zymor 2L Tablet contains Trypsin Chymotrypsin (200000 AU), a proteolytic enzyme combination widely used for its anti-inflammatory, anti-edematous, and fibrinolytic properties. This medication is primarily indicated for the management of acute and chronic inflammatory conditions, including postoperative swelling, trauma-related edema, and soft tissue injuries. Trypsin and chymotrypsin act by breaking down proteinaceous debris at the site of inflammation, facilitating the resolution of edema and promoting tissue repair. Zymor 2L Tablet is also beneficial in enhancing wound healing and reducing pain associated with inflammatory processes. The enzyme preparation aids in improving microcirculation and accelerating the removal of necrotic tissue, thereby supporting faster recovery. It is commonly prescribed as an adjunct therapy in conditions such as arthritis, phlebitis, and postoperative recovery. Administration should be under medical supervision, with dosage tailored according to the severity of the condition and patient response. Caution is advised in patients with hypersensitivity to proteolytic enzymes or those with bleeding disorders, as the drug may increase bleeding risk. Overall, Zymor 2L Tablet offers an effective enzymatic approach to managing inflammation and edema, promoting enhanced healing in various clinical scenarios.